Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Ocean Biomedical, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 25 | 7 | −18 |
| Shares | 4.65M | 812.2K | −3.84M (−82.5%) |
| Value | $247.3K | $5.69K | −$241.7K (−97.7%) |
New holders (2)
Institutions that held Ocean Biomedical, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 421,021 | $3.07K | 0.00% |
| Sage Mountain Advisors LLC | 10,464 | $76 | 0.00% |
Sold out (20)
Institutions that held Ocean Biomedical, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Polar Asset Management Partners Inc. | 2,688,193 | $142.5K |
| Citadel Advisors LLC | 473,098 | $25.5K |
| Vanguard Group Inc | 406,529 | $22.0K |
| UBS Group AG | 246,259 | $13.3K |
| Geode Capital Management, LLC | 161,571 | $8.73K |
| Susquehanna International Group, LLP | 98,427 | $5.32K |
| Revolve Wealth Partners, LLC | 69,570 | $3.76K |
| BlackRock, Inc. | 60,499 | $3.27K |
| State Street Corp | 32,800 | $1.77K |
| Northern Trust Corp | 26,775 | $1.45K |
| 180 Wealth Advisors, LLC | 25,288 | $1.37K |
| Two Sigma Investments, LP | 19,871 | $1.07K |
| Group One Trading, L.P. | 19,002 | $1.03K |
| HBK Sorce Advisory LLC | 11,293 | $610 |
| EverSource Wealth Advisors, LLC | 5,435 | $293 |
| SBI Securities Co., Ltd. | 3,617 | $195 |
| JPMorgan Chase & Co | 233 | $12 |
| Citigroup Inc | 142 | $8 |
| BNP Paribas Arbitrage, SA | 143 | $8 |
| Bank of America Corp | 92 | $5 |